Evaluation of Ebola Virus Inhibitors for Drug Repurposing

A systematic screen of FDA-approved drugs was performed to identify compounds with in vitro antiviral activities against Ebola virus (EBOV). Compounds active (>50% viral inhibition and

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	ACS infectious diseases 2015-07, Vol.1 (7), p.317-326
Hauptverfasser:	Madrid, Peter B, Panchal, Rekha G, Warren, Travis K, Shurtleff, Amy C, Endsley, Aaron N, Green, Carol E, Kolokoltsov, Andrey, Davey, Robert, Manger, Ian D, Gilfillan, Lynne, Bavari, Sina, Tanga, Mary J
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A systematic screen of FDA-approved drugs was performed to identify compounds with in vitro antiviral activities against Ebola virus (EBOV). Compounds active (>50% viral inhibition and
ISSN:	2373-8227 2373-8227
DOI:	10.1021/acsinfecdis.5b00030